International Conference on Perspectives in Precision Medicine, 28 February 2018 - 1 March 2018, Maersk Tower, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark

International Conference on Perspectives in Precision Medicine, 28 February 2018 - 1 March 2018, Maersk Tower, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark

We are facing a paradigm change in the development of more personalised medicine. Research and commercial development in the cross field between public health, health records, biobanks, biomarkers, information and communication technologies, user perspectives and the established fields of the pharmaceutical industry are emerging growth areas.

This International Conference on Perspectives in Precision Medicine will focus on possibilities and challenges in the cross field between pharmaceutical development, user involvement and Information and Communications Technology (ICT). The conference will introduce new cross-disciplinary research fields and bring together key stakeholders and experts in the three converging disciplines: pharmaceutical development, user involvement and ICT. The event will include keynote speakers, panel discussions, thematic round tables, site visits and relevant matchmaking activities, which hopefully can lead to new fruitful partnerships. Everyone with an interest in precision medicine, especially in the cross field between pharmaceutical development, user involvement and ICT, are welcome to attend the conference.

The conference especially targets SMEs, researchers and anyone else who are looking into new insight and knowledge on personalised medicine, want to discover new business and research opportunities, meet potential partners, expand their network, and be inspired by a world leading pharmaceutical hub in the heart of Copenhagen.

Programme

Wednesday 28 February 2018 (Day 1)

08:30-11:30 Optional site visit to the Danish National Biobank

11:30 Arrival, registration and lunch + foyer funding exhibition

12:30 Opening session

  • Conference moderator - Nynne Bjerre Christensen, Journalist
  • Agnete Gersing, Permanent Secretary, Danish Ministry of Higher Education and Science
  • Ulla Wewer, Dean, Professor, Faculty of Health and Medical Sciences, University of Copenhagen
  • Per Spindler, Director, Biopeople – Denmark’s Life Science Cluster, University of Copenhagen

13:00-15:20 Key notes

Building an Enterprise Grade Precision Medicine Infrastructure for Healthcare / Jonathan Sheldon, Jonathan Sheldon, Ph.D., is Senior Vice President and member of the Executive Committee at QIAGEN

Precision Medicine and Biomarkers / Nils Brünner, Professor, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen

Korean Precision Medicine Enterprise – innovative initiative / Yeul Hong Kim, Professor, Korea University College of Medicine Director, Korean Precision Medicine Enterprise

15:20-16:30 Panel discussion led by conference moderator

  • Alain Van Gool, Professor of Personalized Health Care, Radboudumc, Head Translational Metabolic Laboratory, Radboud University Medical Center
  • Jonathan Sheldon, Jonathan Sheldon, Ph.D., is Senior Vice President and member of the Executive Committee at QIAGEN
  • Helle B. Konradsen, Director, MD, Management of the Danish National Biobank, Statens Serum Institut (SSI)
  • Nils Brünner, Professor, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen
  • Mette Nordahl Svendsen, Professor mso, Department of Public Health, Section of Health Services Research , University of Copenhagen
  • Yeul Hong Kim, Professor, Korea University College of Medicine Director, Korean Precision Medicine Enterprise

16:45-18:15 Match making & foyer funding exhibition - pre-booked meetings

18:15-20:00 Reception & light dinner, Executive Floor of the Maersk Tower, University of Copenhagen

Thursday 1 March 2018 (Day 2)

08:30 Welcome coffee

09:00-10:00 Key notes

Biobanks in Precision Medicine – National strategies / Helle B. Konradsen, Director, MD, Management of the Danish National Biobank, Statens Serum Institut (SSI)

Developing a shared infrastructure for personalised health and medicine research: experience from the Netherlands / Alain Van Gool, Professor of Personalized Health Care, Radboudumc, Head Translational Metabolic Laboratory, Radboud University Medical Center

10:15-10:40 Biomarkers and Personalised Medicine as Emerging Growth Area in Denmark / Kim Holmstroem, Bioneer, The Danish Biomarker Network

10:45-11:40 Round table discussions on challenges and opportunities in the cross field between pharma, ICT and user involvement

11:40-12:00 Summary of round tables discussions

12:00-12:10 Wrap up & farewell

12:10-13:15 Lunch

13:15-16:00 Optional site visit to Bioneer A/S

 

 

The Danish biobanks swings with precision medicine
The Danish biobanks swings with precision medicine 09-01-2018
"...together with the outstanding population registers in Denmark, the Danish National Biobank and the Danish Biobank Register offer unprecedented...
International Conference on perspectives in precision medicine in Copenhagen in February 2018
International Conference on perspectives in precision medicine in Copenhagen in February 2018 27-09-2017
We are facing a paradigm change with challenges. Research and commercial development in the cross field between public health, health records, bio...
Dr. Kim of the Korean Precision Medicines Enterprice is confirmed as speaker at the International Conference on Perspectives in Precision Medicine
Dr. Kim of the Korean Precision Medicines Enterprice is confirmed as speaker at the International Conference on Perspectives in Precision Medicine 02-01-2018
Dr. Yeul Hong Kim, Professor at Korea University College of Medicine & Director of the Korean Precision Medicine Enterprise will present the...
Professor Alain van Gool is confirmed as speaker at the International Conference on Perspectives in Precision Medicine
Professor Alain van Gool is confirmed as speaker at the International Conference on Perspectives in Precision Medicine 05-01-2018
Alain van Gool is professor Personalized Healthcare and heads the Translational Metabolic Laboratory at the Radboud University Medical Center - with a...

Denmark has a unique international position in addressing the interrelationship between pharmaceutical R&D, ICT and user involvement

Denmark has a unique international position in addressing the interrelationship between pharmaceutical R&D, ICT and user involvement
  • Denmark is home to the most innovative biotech industries in the world and Denmark is ranked as the best country in Europe for development of biotechnology. This includes strong R&D collaborations with Danish universities and research organisations and a high degree of interdisciplinary involvement.
  • The Danish biotech industry comprises more than 160 companies, employs approximately 40,000 people, including more than 5,000 dedicated R&D employees. Together with the 8 universities, 7 science parks and 4 major university hospitals this makes a unique platform.
  • In 2017, Denmark launched a national strategy on Personalised Medicine based on a yearlong systematic collection of data and knowledge about the Danish population’s diseases and treatment. In relation to this, Denmark opened their first National Genome Center, which will unfold the potential of personalised medicine.
  • Denmark is a highly developed ICT nation and as such has a unique and strong environment for developing ICT solutions, which address health related needs and challenges.
  • The Danish digital eco system has a strong technological foundation for system development integrating hardware and software and it comprises one of the most competitive and advanced telecommunications infrastructure and mobile markets. This in particular will be central for the development of new smart products for applications in health.
  • User involvement in health care has become an important focus area in Denmark in relation to safety issues, self-care, partnerships in biomedical R&D and others. Patients are already involved in many ways, however, both ICT and pharmaceutical research & development could benefit even more from partnering with "users" and patients.
International Conference on Perspectives in Precision Medicine

MANDATORY REGISTRATION HERE (THE REGISTRATION IS CLOSED - CONTACT PESP@BIOPEOPLE.KU.DK FOR ANY ENQUIRY)

Participation is free of charge. Registration includes programme material, one-on-one meetings, breaks, lunch and dinner reception.

There is a no-show-fee of 15.000 DKK if cancellation is not made in written to pesp@biopeople.ku.dk latest by 24 February 2018.

If registrations exceeds the capacity of the facilities, the organisers will discretly refer to waiting list.

No on-site registrations will be allowed.

Matchmaking with face-to-face meetings 28 February 2018 (16:45-18:15): register here

Conference attendees are invited to pre-book bilateral meetings of 15 minutes with other persons participating in the International Conference on Perspectives in Precision Medicine.

The matchmaking event is a platform offering opportunities to meet potential customers, suppliers, research partners, project partners, investors for new business and R&D projects etc.

Each participant can pre-book a number of meetings and a personal meeting schedule will be available four days ahead of the event.

OPTIONAL SITE VISITS

28 February 2018, 9:15-11:15 - The Danish National Biobank

1 March 2018, 13:15-16:00 - Bioneer A/S

The site visits are offered to participants of the conference and is free of charge. Bus transportation t/r will be organised from the conference venue. Registration is mandatory, please follow the links above.  

(THE REGISTRATION IS CLOSED - CONTACT PESP@BIOPEOPLE.KU.DK FOR ANY ENQUIRY)

Organisers:

Organisers:
Organisers:
Organisers:
International Conference on Perspectives in Precision Medicine

Conference Contacts

Ms. Anette Day, Global Cooperation on Research and Education, Danish Agency for Science and Higher Education, amu@ufm.dk

Mr. Bjarne Andersen, Enterprise Europe Network, ban@southdenmark.be

Dr. Per Spindler, Director, Biopeople, pesp@biopeople.ku.dk

Close
What are you looking for?
This site uses the functionality that older versions of Internet Explorer does not support. You should therefore switch or upgrade your browser.